| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/21/2006 | CA2601051A1 Use of inhibitors of steroid (testosterone) activity (i. a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 09/21/2006 | CA2600568A1 Prophylactic/therapeutic agent for cancer |
| 09/20/2006 | EP1703014A1 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 09/20/2006 | EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2006 | EP1702927A1 Attenuated microorganisms for the treatment of infection |
| 09/20/2006 | EP1702926A1 Levulose glucoselipid a analogue |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702919A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1702910A1 Octahydronaphthalene derivative and medicine |
| 09/20/2006 | EP1702626A1 Inhibitor for the formation of gammad-secretase complex |
| 09/20/2006 | EP1702623A2 Use of interferon gamma for the treatment of cardiac hypertrophy |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701732A2 Sulfhydryl protected glutathione prodrug |
| 09/20/2006 | EP1701721A1 Use of pilocarpine for hypoptyalism treatment |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1497308B1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 09/20/2006 | EP1404815B1 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/20/2006 | EP1392363B1 Use of mGLuR5 antagonists in the manufacture of a medicament in the treatment of Fragile X syndrome, Autism and Mental Retardation |
| 09/20/2006 | EP1368364B1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP1272188B1 Use of egfr tyrosine kinase inhibitors for treating brest cancer |
| 09/20/2006 | EP1158970B1 Combinations of formoterol and a tiotropium salt |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | EP0774004B1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835766A Osteogenesis promoter |
| 09/20/2006 | CN1834104A Lactose with first anti-adhesion activity and its fluorescent mark |
| 09/20/2006 | CN1833722A Health products for face care and body care |
| 09/20/2006 | CN1833664A Pterigospermin capsules and prodn. method |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 09/20/2006 | CN1275962C Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/20/2006 | CN1275626C External used Chinese medicinal composition for abdominal external hernia |
| 09/20/2006 | CN1275615C Levulose absorption retardant, compound, food and levulose absorption repressor |
| 09/20/2006 | CN1275600C Vitamin-medicine composition and its use |
| 09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109341 Antitumor agents; such as 2-(4-((7-Bromo-2-quinolinyl)oxy)phenoxy)propionmethylamide |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109322 Process for the depletion or removal of endotoxins |
| 09/19/2006 | US7109316 New class of nucleoside triphosphates that contain an oligonucleotide of random or defined sequence attached to the base and are substrates for polymerases and terminal nucleotidyl transferases is described |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109235 Microtubule stabilizing compounds |
| 09/19/2006 | US7109234 Benzoxathiepine derivatives and their use as medicines |
| 09/19/2006 | US7109231 Antiinflammatory agents; sepsis |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/19/2006 | US7109210 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 09/19/2006 | US7109208 Rho kinase inhibitors having axon of the retinal ganglion cellal extension- and optic nerve cell regeneration- promoting action, particularly (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide |
| 09/19/2006 | US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109201 5-HT1D receptor antagonist activity; antidepressants |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109195 Hexacyclic compounds and their therapeutic use |
| 09/19/2006 | US7109193 Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109181 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7109160 Peptides containing the motif IGD and their use as cell migration modulators |
| 09/19/2006 | US7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 09/19/2006 | US7108861 Environmentally benign crop protection agents |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/19/2006 | CA2140989C Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnosticagent, and a medicament containing them |
| 09/14/2006 | WO2006096481A1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease |
| 09/14/2006 | WO2006095922A1 Tetrahydroisoquinoline compound and medicinal use thereof |
| 09/14/2006 | WO2006095897A1 Screening method |
| 09/14/2006 | WO2006095844A1 Pharmaceutical preparation |
| 09/14/2006 | WO2006095783A1 Novel hsp90 inhibitor |
| 09/14/2006 | WO2006095723A1 Antiallergic drug |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095711A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095636A1 Novel compound selectively activated at target site and utilization of the same |